Ascendis Pharma A/s Earnings

Ascendis Pharma A/s’s revenue jumped 5.28% since last year same period to $100.95Mn in the Q1 2025. On a quarterly growth basis, Ascendis Pharma A/s has generated -41.95% fall in its revenue since last 3-months.

Ascendis Pharma A/s’s net profit jumped 27.79% since last year same period to $-94.63Mn in the Q1 2025. On a quarterly growth basis, Ascendis Pharma A/s has generated -145.98% fall in its net profits since last 3-months.

Ascendis Pharma A/s’s net profit margin jumped 31.41% since last year same period to -93.73% in the Q1 2025. On a quarterly growth basis, Ascendis Pharma A/s has generated -323.76% fall in its net profit margins since last 3-months.

Ascendis Pharma A/s’s earning per share (EPS) estimates for the current quarter stand at -0.75 - a 45% jump from last quarter’s estimates.

Ascendis Pharma A/s’s earning per share (EPS) estimates for the current year stand at -0.75.

Ascendis Pharma A/s’s earning per share (EPS) jumped 100% since last year same period to 0 in the Q3 2025. This indicates that the Ascendis Pharma A/s has generated 100% annual rate of jump in its earning per share (EPS) in the last 4 quarters.